If yours is marked in tenths of a milliliter instead, skip to the 1 mL syringe section below
A facelift patient gets the skin and incision benefit of GHK-Cu more than anything else, so I prescribe GLOW
BPC-157 vs TB-500 BPC-157 is generally studied for localized tissue-protection, angiogenesis, and gastric-barrier pathways, while TB-500 is studied for actin regulation, cellular migration, and broader systemic recovery models
Is there any obvious contraindications or disqualifiers
In terms of documented efficacy, this is not a close comparison: GLP-1 S has shown weight reductions in the range of 13-20% of body weight in clinical trials, while AOD-9604s pivotal trial failed to demonstrate a significant effect at that scale
The medication reduces appetite and helps regulate blood sugar